Related Experiment Video
Updated: Jun 11, 2025
MRI and PET in Mouse Models of Myocardial Infarction
Published on: December 19, 2013
Recent advances in PET-MRI for cardiac sarcoidosis
Camila Munoz1, Alina Schneider1, René M Botnar1,2,3,4
1School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.
Insights
Diagnosing cardiac sarcoidosis (CS) is difficult. Hybrid PET-MRI shows promise for accurate CS detection and risk stratification, potentially becoming the preferred diagnostic tool.
Area of Science:
- Cardiology
- Medical Imaging
- Oncology
Background:
- Cardiac sarcoidosis (CS) diagnosis is challenging, despite its association with adverse outcomes like arrhythmias and heart failure.
- No gold-standard diagnostic technique currently exists for CS.
- Early and accurate diagnosis is clinically relevant for patient management.
Purpose of the Study:
- To review recent advancements in hybrid PET-MR imaging for diagnosing CS.
- To discuss the potential of cardiac PET-MRI as a leading diagnostic tool for CS.
Main Methods:
- Review of recent developments in hybrid PET-MR imaging techniques.
- Analysis of the sensitivity and specificity of PET-MR for CS detection and risk stratification.
Main Results:
- Hybrid PET-MR scanners acquire PET and MR data in a single session.
- Hybrid PET-MR demonstrates higher sensitivity and specificity for CS detection compared to individual modalities.
- This integrated approach aids in risk stratification for patients with CS.
Conclusions:
- Hybrid PET-MR imaging represents a significant advancement in diagnosing cardiac sarcoidosis.
- Further development could establish cardiac PET-MRI as the preferred comprehensive diagnostic tool for CS.
- Improved diagnostic accuracy can lead to better patient outcomes.
Abstract:
The diagnosis of cardiac sarcoidosis (CS) remains challenging. While only a small fraction of patients with systemic sarcoidosis present with clinically symptomatic CS, cardiac involvement has been associated with adverse outcomes, such as ventricular arrhythmia, heart block, heart failure and sudden cardiac death. Despite the clinical relevance of having an early and accurate diagnosis of CS, there is no gold-standard technique available for the assessment of CS. Non-invasive PET and MR imaging have shown promise in the detection of different histopathological features of CS. More recently, the introduction of hybrid PET-MR scanners has enabled the acquisition of these hallmarks in a single scan, demonstrating higher sensitivity and specificity for CS detection and risk stratification than with either imaging modality alone. This article describes recent developments in hybrid PET-MR imaging for improving the diagnosis of CS and discusses areas of future development that could make cardiac PET-MRI the preferred diagnostic tool for the comprehensive assessment of CS.
More Related Videos
Related Concept Videos
01:21Imaging Studies for Cardiovascular System IV: CMRI
01:29Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy